<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>18(2)</volume><submitter>Harley G</submitter><funding>University of Melbourne</funding><funding>National Health and Medical Research Council</funding><pubmed_abstract>The anti-fibrotic effect of metformin has been widely demonstrated. Fibrosis in the kidney after injury is associated with reduced expression of genes involved in both fatty acid and glycolytic energy metabolism. We have previously reported that the anti-fibrotic effect of metformin requires phosphoregulation of fatty acid oxidation by AMP-activated protein kinase (AMPK). To determine whether metformin also acts via regulation of glycolysis, we mutated regulatory phosphosites in the PFKFB2 isoform of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase (PFKFB2), a key regulator of glycolysis in the kidney. Mice with inactivating knockin (KI) mutations of the phosphorylation sites in PFKFB2 (PFKFB2 KI mice), which reduces the ability to increase the rate of glycolysis following stimulation, </pubmed_abstract><journal>PloS one</journal><pagination>e0280792</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9910667</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Mutation of regulatory phosphorylation sites in PFKFB2 does not affect the anti-fibrotic effect of metformin in the kidney.</pubmed_title><pmcid>PMC9910667</pmcid><pubmed_authors>Katerelos M</pubmed_authors><pubmed_authors>Harley G</pubmed_authors><pubmed_authors>Mount PF</pubmed_authors><pubmed_authors>Lee M</pubmed_authors><pubmed_authors>Gleich K</pubmed_authors><pubmed_authors>Power DA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Mutation of regulatory phosphorylation sites in PFKFB2 does not affect the anti-fibrotic effect of metformin in the kidney.</name><description>The anti-fibrotic effect of metformin has been widely demonstrated. Fibrosis in the kidney after injury is associated with reduced expression of genes involved in both fatty acid and glycolytic energy metabolism. We have previously reported that the anti-fibrotic effect of metformin requires phosphoregulation of fatty acid oxidation by AMP-activated protein kinase (AMPK). To determine whether metformin also acts via regulation of glycolysis, we mutated regulatory phosphosites in the PFKFB2 isoform of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase (PFKFB2), a key regulator of glycolysis in the kidney. Mice with inactivating knockin (KI) mutations of the phosphorylation sites in PFKFB2 (PFKFB2 KI mice), which reduces the ability to increase the rate of glycolysis following stimulation, </description><dates><release>2023-01-01T00:00:00Z</release><publication>2023</publication><modification>2025-05-18T11:39:09.987Z</modification><creation>2025-05-18T11:39:09.987Z</creation></dates><accession>S-EPMC9910667</accession><cross_references><pubmed>36757995</pubmed><doi>10.1371/journal.pone.0280792</doi></cross_references></HashMap>